KUALA LUMPUR: Amway (Malaysia) Holdings Bhd reported a 17.5% year-on-year (y-o-y) decline in net profit to RM12.07 million for the third quarter ended Sept 30, 2026, from RM14.62 million a year earlier, amid softer consumer demand.
Revenue fell 6.3% to RM258.28 million from RM275.55 million, while profit before tax declined 11.8% to RM16.18 million.
For the nine months ended Sept 30, 2026, revenue decreased 5.3% y-o-y to RM792.07 million, while net profit fell 12.5% to RM26.49 million. Profit before tax slipped 8.7% to RM36.32 million.
The company attributed the weaker performance to subdued consumer spending, lower sales volumes and higher sales and marketing expenses. Revenue was also affected by a higher base of comparison following the launch of cellular health products in the corresponding quarter last year.
Amway expects market conditions to remain challenging for the rest of 2026, with consumers likely to remain cautious in their spending.
The company said it would continue focusing on the health and wellness segment while strengthening its sales capabilities, product innovation and investments in digital and physical infrastructure.
Separately, the board declared a third interim dividend of five sen per share for the 2026 financial year, payable on Dec 18, 2026. The ex-dividend date and other payment details will be announced later.
